These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19039936)

  • 1. Effect of antiparkinsonian drug himantane on the content of dopamine transporter DAT protein in rat striatum and cultured pheochromocytoma PC-12 cells.
    Abaimov DA; Zenina-Antipova TA; Kovalev GI; Seredenin SB
    Bull Exp Biol Med; 2008 Mar; 145(3):331-3. PubMed ID: 19039936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The acute and subchronic effects of hemantane on [3H]-dopamine reuptake in rat striatal synaptosomes ex vivo].
    Abaimov DA; Kovalev GI
    Eksp Klin Farmakol; 2007; 70(4):11-4. PubMed ID: 18078034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
    Zimin IA; Logvinov IO; Antipova TA; Kovalev GI
    Eksp Klin Farmakol; 2011; 74(1):11-4. PubMed ID: 21476268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
    Andiarzhanova EA; Val'dman EA; Kudrin VS; Raevskiĭ KS; Voronina TA
    Eksp Klin Farmakol; 2001; 64(6):13-6. PubMed ID: 11871228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
    Abaimov DA; Zimin IA; Kovalev GI
    Eksp Klin Farmakol; 2008; 71(1):18-21. PubMed ID: 18365481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
    Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
    Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(3):44-6. PubMed ID: 12924233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the distribution of 3[H]-himantane in the brain structures and the thymus of rats].
    Kovalev GI; Rodionov AP; Petrenko ES; Zolotarev IuA
    Eksp Klin Farmakol; 2003; 66(3):50-2. PubMed ID: 12924235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotropic activity of a potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Voronina TA
    Eksp Klin Farmakol; 2001; 64(2):60-3. PubMed ID: 11548451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological activity of the new adamantane derivative--potential antiparkinson preparation during subchronic administration].
    Val'dman EA
    Eksp Klin Farmakol; 2000; 63(5):3-6. PubMed ID: 11109514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter trafficking is regulated by neutral sphingomyelinase 2/ceramide kinase.
    Won JH; Kim SK; Shin IC; Ha HC; Jang JM; Back MJ; Kim DK
    Cell Signal; 2018 Apr; 44():171-187. PubMed ID: 29329781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studies.
    Nikolaus S; Antke C; Hautzel H; Mueller HW
    Nuklearmedizin; 2016; 55(1):21-8. PubMed ID: 26642370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
    Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
    J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with haloperidol reduces (123)I-FP-CIT binding to the dopamine transporter in the rat striatum: an in vivo imaging study with a dedicated small-animal SPECT camera.
    Nikolaus S; Antke C; Kley K; Beu M; Wirrwar A; Müller HW
    J Nucl Med; 2009 Jul; 50(7):1147-52. PubMed ID: 19525450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine.
    Nikolaus S; Beu M; Angelica De Souza Silva M; Huston JP; Hautzel H; Antke C; Müller HW
    Synapse; 2016 Sep; 70(9):369-77. PubMed ID: 27164322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the inhibitory effects of certain antiparkinsonian agents on dopamine accumulation into the rat striatum.
    Nose T; Segawa T
    Jpn J Pharmacol; 1974 Apr; 24(2):299-305. PubMed ID: 4152745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.